Trixeo Aerosphere Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Riltrava Aerosphere Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Trimbow Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate disodný, glycopyrronium bromid - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Trydonis Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

trydonis

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate disodný, glycopyrronium - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - udržiavacia liečba u dospelých pacientov so stredne závažnou až závažnou chronickou obštrukčnou chorobou pľúc (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačného kortikosteroidu a dlhodobo pôsobiaci beta2-agonista (pre ovplyvnenie príznakov a prevencie exacerbácií pozri časť 5.

Axhidrox Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

axhidrox

dr. august wolff gmbh & co. kg arzneimittel, nemecko - glykopyrónium - 46 - dermatologica

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

riarify (previously chf 5993 chiesi farmaceutici s.p.a.)

chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - udržiavacia liečba u dospelých pacientov so stredne závažnou až závažnou chronickou obštrukčnou chorobou pľúc (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačného kortikosteroidu a dlhodobo pôsobiaci beta2-agonista (pre ovplyvnenie príznakov a prevencie exacerbácií pozri časť 5.